Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Hypertension. 2021 Feb 15;77(4):1323–1331. doi: 10.1161/HYPERTENSIONAHA.120.14808

Figure 1: Plasma 14,15- and Total EETs increased after treatment of primary aldosteronism.

Figure 1:

Plasma total (▼), 14,15- (●), 11,12- (●), and 8,9 (○)-epoxyeicosatrienoic acid (EET, A) and dihydroxyeicosatrienoic acid (DHET, B) concentrations before (Pre) and three to twelve months after (Post) treatment of primary aldosteronism. Soluble epoxide hydrolase (sEH) activity was estimated indirectly by the molar ratios of individual and total DHET/(EET+DHET) (C). Data for individual EET concentrations appear in Figure S1.